It’s pancreatic cancer month. Listen to Dr. Clark and Verne Hill on WBFJ 89.3 discuss pancreatic cancer diagnosis, treatment, and prevention. Recorded on November 11, 2020.
Dong and colleagues present a retrospective study evaluating risk factors associated with tumor recurrence for patients with non-functional pancreatic neuroendocrine tumors. This study includes over 800 patients from the US Neuroendocrine Study Group. The results of their study indicate that
Dr. Clark joins Joel Weissman, PhD, and a team of researchers at Brigham and Women’s Hospital in an effort to improve surgical decision-making for persons living with Dementia. The study is titled: “Decisions Around Dementia and Surgery” (aka the DecADES
In the most recent edition of the Journal of the American College of Surgeons (Volume 231, Issue 2), Drs. Lovasik and Sarmiento discuss their approach to helping patients recovery after major liver and pancreas surgery. Making a phone call to
Wake Forest Baptist Health will be joining the Alliance clinical trial A021806. This phase III that compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed